Advances in kinase inhibition: treating rheumatic diseases and beyond.
about
A novel flow cytometric-based method to measure kinase inhibition in sputum from COPD subjects.Signaling mechanisms regulating B-lymphocyte activation and tolerance.Multiple signals at the extended 8p23 locus are associated with susceptibility to systemic lupus erythematosus.Decernotinib: A Next-Generation Jakinib.The role of the JAK/STAT signal pathway in rheumatoid arthritis.
P2860
Advances in kinase inhibition: treating rheumatic diseases and beyond.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Advances in kinase inhibition: treating rheumatic diseases and beyond.
@ast
Advances in kinase inhibition: treating rheumatic diseases and beyond.
@en
type
label
Advances in kinase inhibition: treating rheumatic diseases and beyond.
@ast
Advances in kinase inhibition: treating rheumatic diseases and beyond.
@en
prefLabel
Advances in kinase inhibition: treating rheumatic diseases and beyond.
@ast
Advances in kinase inhibition: treating rheumatic diseases and beyond.
@en
P2860
P1476
Advances in kinase inhibition: treating rheumatic diseases and beyond.
@en
P2093
Massimo Gadina
P2860
P304
P356
10.1097/BOR.0000000000000023
P577
2014-03-01T00:00:00Z